Bristol-Myers Squibb buy Bank of America Co.
Start price
27.12.23
/
50%
€46.75
Target price
27.12.24
€61.40
Performance (%)
18.50%
End price
28.12.24
€55.40
Summary
This prediction ended on 28.12.24 with a price of €55.40. The prediction had a final performance of 18.50%. Bank_of_America_Co_ has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Buy. Dividends of €2.20 are taken into consideration when calculating the performance. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | 5.226% | 5.226% | -12.331% |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Bank of America Co. from $72.00 to $68.00. They now have a "buy" rating on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€45.99
15.12.25
15.12.25
€51.96
15.12.26
15.12.26
4.42%
09.01.26
09.01.26
